Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | TERT | O14746 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 2/20 | 0.34 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MMP3 | P08254 | 1/20 | 0.34 |
| ▸ | MMP9 | P14780 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CTSD | P07339 | 1/20 | 0.31 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19985684 | 1.00 | MCL1 (0.41) | MCL1FAAHTERTMMP2MMP1 | |
| SCHEMBL17874650 | 1.00 | MCL1 (0.41) | MCL1FAAHTERTMMP2MMP1 | |
| SCHEMBL1536829 | 0.90 | — | — | |
| Hydrochloric Acid SCHEMBL3649029 | 0.87 | — | — | |
| Ammonia Solution, Strong SCHEMBL27540199 | 0.87 | — | — | |
| Water SCHEMBL27489158 | 0.87 | — | — | |
| SCHEMBL19057292 | 0.82 | TDP1 (0.38) | TERTKMT2ACA1CA2MEN1 | |
| SCHEMBL19446214 | 0.82 | MCL1 (0.45) | MCL1TERTMMP2MMP1MMP3 | |
| SCHEMBL22420468 | 0.82 | MCL1 (0.45) | MCL1TERTMMP2MMP1MMP3 | |
| SCHEMBL24261804 | 0.81 | TERT (0.39) | TERTMMP2CA1CA2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017082753-A1 | GLYCOLIPID COMPOUNDS AND THEIR USES IN THE TREATMENT OF TUMOURS | AGALIMMUNE LIMITED (GB) | 2017-05-18 | — | — | WO | disclosed |
| US-9221879-B2 | Multiligand constructs | SEMIOTIK LLC (RU) | 2015-12-29 | — | — | US | disclosed |
| US-20140135477-A1 | MULTILIGAND CONSTRUCTS | SEMIOTIK LLC (RU) | 2014-05-15 | — | — | US | disclosed |
| US-20090264300-A1 | ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES | NUEVOLUTION A/S (DK) | 2009-10-22 | — | — | US | disclosed |
| US-7226578-B2 | Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis | SHERING AG (DE) | 2007-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264300-A1 | ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES | RNGTT, DUT, EMG1 | MCL1 4151/4885FAAH 2027/4885TERT 753/4885 |
| US-20140135477-A1 | MULTILIGAND CONSTRUCTS | KLK3, CD2BP2, PAICS | MCL1 42/4885FAAH 3689/4885TERT 2362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.